Champions Oncology (CSBR) Current Assets (2011 - 2026)

Champions Oncology's Current Assets history runs 16 years deep, the most recent figure standing at $20.2 million for Q1 2026.

• In Q1 2026, Current Assets rose 2.48% year-over-year to $20.2 million; the TTM figure through Jan 2026 stood at $20.2 million (up 2.48% YoY), while the FY2025 annual figure was $22.4 million, up 63.93% from the prior year.
• Current Assets was $20.2 million for Q1 2026 at Champions Oncology, down from $21.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $22.4 million in Q2 2025 to a low of $13.2 million in Q3 2024.
• Historically, Current Assets has averaged $17.9 million across 5 years, with a median of $19.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Assets sank 35.17% in 2024, then surged 63.93% in 2025.
• A 5-year view of Current Assets shows it stood at $20.6 million in 2022, then tumbled by 31.98% to $14.0 million in 2023, then climbed by 0.48% to $14.1 million in 2024, then soared by 51.46% to $21.3 million in 2025, then fell by 5.38% to $20.2 million in 2026.
• The last three Current Assets figures came in at $20.2 million (Q1 2026), $21.3 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.